Longitudinal study of the flash glucose monitoring system in type 1 diabetics: An mHealth ally in times of COVID-19

被引:2
作者
Cervantes-Torres, Laura [1 ,2 ]
Romero-Blanco, Cristina [2 ]
机构
[1] Family & Community Nursing, Ciudad Real, Spain
[2] Univ Castilla La Mancha, Dept Nursing, Ciudad Real, Spain
关键词
blood glucose; diabetes Mellitus; type; 1; glycated haemoglobin A; mHealth; nursing care; treatment adherence and compliance; BLOOD-GLUCOSE; SENSING TECHNOLOGY; ASSOCIATION; MULTICENTER; STATEMENT; MANAGEMENT; FREQUENCY;
D O I
10.1111/jocn.16523
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aims and objectives The aim of this study was to assess the effect of the FreeStyle Libre device implantation in adult type 1 diabetics in a Health Area of Castilla La Mancha (Spain) during the COVID-19 pandemic. Background FreeStyle Libre is a so-called mHealth device that supports health care. During COVID-1 confinement, diabetic patients could have improved their glycaemic monitoring thanks to these devices, although health care in these patients may have been limited due to confinement. Methods A 12-month longitudinal study in which a total of 206 type I diabetics participated, belonging to a single health area. Sociodemographic and analytical data and the Self Care Inventory Revised questionnaire (SCI-R) were collected. STROBE checklist was followed. Results The analysis showed differences related to the use of the sensor. After the study period, patients obtained better levels of basal glucose, glycosylated haemoglobin, creatinine, cholesterol, triglycerides and LDL. In addition, a significant increase in the total score of the SCI-R questionnaire was observed after the use of the monitor (MD -7.77; 95% CI -10.43, -8.29). The same occurred with different SCI-R items such as diet (MD -2.995; 95% CI -3.24, -2.57), glucose determination (MD -3.21; 95% CI -3.52, -2.91), medication administration (MD -2.58; 95% CI -2.53, -1.96) and hypoglycaemic episodes (MD -1.07; 95% CI -1.21, -0.93). In the analysis by groups, worse values of glycosylated haemoglobin and adherence to treatment (p < .05) were observed in overweight/obese subjects versus those with normal weight after one year of study. Conclusion The use of flash monitoring is related to better adherence to most of the recommended habits in diabetes. Nevertheless, there seems to be no relationship with an improvement in physical exercise and preventive aspects of diabetes. A good nursing intervention to support physical exercise and the use of mHealth devices could improve the control of diabetic patients. Relevance to clinical practice The use of this mHealth device has shown positive results and reduced complications. Despite less contact with healthcare facilities due to the pandemic, type 1 diabetic patients have improved their blood results and adherence after using the device for one year. Nursing staff should focus on promoting physical activity and routine disease care in type 1 diabetics.
引用
收藏
页码:3840 / 3851
页数:12
相关论文
共 53 条
  • [1] Abed Alah Muna, 2021, Metabol Open, V12, P100144, DOI 10.1016/j.metop.2021.100144
  • [2] Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system
    Ajjan, Ramzi A.
    Cummings, Michael H.
    Jennings, Peter
    Leelarathna, Lalantha
    Rayman, Gerry
    Wilmot, Emma G.
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (01) : 3 - 12
  • [3] Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features
    Akturk, Halis Kaan
    Dowd, Robert
    Shankar, Kaushik
    Derdzinski, Mark
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : S21 - S26
  • [4] Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump
    Al Hayek, Ayman A.
    Robert, Asirvatham Alwin
    Al Dawish, Mohamed Abdulaziz
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (05)
  • [5] Glycemic Targets: Standards of Medical Care in Diabetes-2018
    不详
    [J]. DIABETES CARE, 2018, 41 : S55 - S64
  • [6] Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
    Bergenstal, Richard M.
    Ahmann, Andrew J.
    Bailey, Timothy
    Beck, Roy W.
    Bissen, Joan
    Buckingham, Bruce
    Deeb, Larry
    Dolin, Robert H.
    Garg, Satish K.
    Goland, Robin
    Hirsch, Irl B.
    Klonoff, David C.
    Kruger, Davida F.
    Matfin, Glenn
    Mazze, Roger S.
    Olson, Beth A.
    Parkin, Christopher
    Peters, Anne
    Powers, Margaret A.
    Rodriguez, Henry
    Southerland, Phil
    Strock, Ellie S.
    Tamborlane, William
    Wesley, David M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (03) : 198 - 211
  • [7] Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect
    Biamonte, Emilia
    Pegoraro, Francesco
    Carrone, Flaminia
    Facchi, Isabella
    Favacchio, Giuseppe
    Lania, Andrea Gerardo
    Mazziotti, Gherardo
    Mirani, Marco
    [J]. ENDOCRINE, 2021, 72 (03) : 604 - 610
  • [8] Bidonde J., 2017, FREESTYLE LIBRE FLAS
  • [9] Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
    Bolinder, Jan
    Antuna, Ramiro
    Geelhoed-Duijvestijn, Petronella
    Kroeger, Jens
    Weitgasser, Raimund
    [J]. LANCET, 2016, 388 (10057) : 2254 - 2263
  • [10] mHealth Assessment: Conceptualization of a Global Framework
    Bradway, Meghan
    Carrion, Carme
    Vallespin, Barbara
    Saadatfard, Omid
    Puigdomenech, Elisa
    Espallargues, Mireia
    Kotzeva, Anna
    [J]. JMIR MHEALTH AND UHEALTH, 2017, 5 (05):